Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa

@article{Comte2013SurvivalOB,
  title={Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepa},
  author={Alexandre Comte and W. Jdid and M. N. Guilhaume and Ir{\'e}ne Kriegel and S Piperno-neumann and V{\'e}ronique Di{\'e}ras and Thierry Dorval and Jean Yves Pierga and Paul Cottu and Laurent Mignot and François Cl{\'e}ment Bidard},
  journal={Journal of Neuro-Oncology},
  year={2013},
  volume={115},
  pages={445-452}
}
Treatment of breast cancer meningeal carcinomatosis (MC) relies on intrathecal chemotherapy. Thiotepa is one of the few drugs approved in this setting, although no large cohort has been reported. The aim of our retrospective study is to describe survival and prognostic factors of breast cancer patients treated by intrathecal thiotepa. A search in the electronic database of the Institut Curie was performed and retrieved the patients diagnosed with breast cancer MC from 2000 to 2012 and who… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Neoplastic meningitis.

Current neurology and neuroscience reports • 2008
View 13 Excerpts
Highly Influenced

Neoplastic meningitis

A VanHorn, MC Chamberlain
J Support Oncol • 2012

Survival of breast cancer patients with meningeal carcinomatosis.

Annals of oncology : official journal of the European Society for Medical Oncology • 2010

Similar Papers

Loading similar papers…